Invention Application
- Patent Title: CD20-PD1 BINDING MOLECULES AND METHODS OF USE THEREOF
-
Application No.: PCT/US2022/079530Application Date: 2022-11-09
-
Publication No.: WO2023086812A1Publication Date: 2023-05-19
- Inventor: SHEN, Yang , WANG, Bei , AVVARU, Naga Suhasini , LIN, Chia-Yang , MURPHY, Andrew , HERMANN, Aynur , KIM, Jee H.
- Applicant: REGENERON PHARMACEUTICALS, INC.
- Applicant Address: 777 Old Saw Mill River Road
- Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee Address: 777 Old Saw Mill River Road
- Agency: ABU-SHAAR, Muna et al.
- Priority: US63/278,374 2021-11-11
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K14/705
Abstract:
The present disclosure relates to molecules capable of binding to both CD20 and PD1, as well as pharmaceutical compositions comprising such molecules and methods of use thereof.
Information query
